Seveno backs PointFit wearable patch

February 25, 2026

Seveno Capital has announced an investment in PointFit, a Hong Kong-based medtech company developing a next-generation wearable patch designed to continuously monitor biomarkers through sweat. The deal marks another step in Seveno’s strategy of backing technologies that sit at the intersection of performance, prevention and longevity – areas where consumer hardware is increasingly converging with clinical-grade ambition.

PointFit’s platform centers on a flexible skin-adherent patch capable of real-time lactate monitoring, with plans to expand into additional sweat-based biomarkers. Positioned initially toward endurance athletes and high-performance users, the company describes a pathway toward broader applications in metabolic health and preventative care. Longevity